Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think there is more selling coming today/tomorrow. Then up. $1.20 resistance and when through, back to your range.
I swing for dollars not pennies.
I did that on Friday at $1.12. Feeling good about this week and PPS action.
The only way they "present" anything at SNO is if the TLD/Journal are out before. Then they can discuss results in detail. Journal will control timing of talking points with whatever embargo they place. SO, that will have to come first, IMO. Unless, of course, there are no Journals who want the article, which would be bad.
I think we get the move back up this afternoon. Maye not green, but close.
We are 13 months from data lock. That's the norm. The company has cited delays. Not to mention the complications and understanding of using comparable trials, which is new to the process. That's why I think we see article in the first quarter.
Manufacturing is not part of the TLD hold up. Separate, but concurrent efforts and milestones. TLD/Journal article are in a lot of hands and those requests from peer reviewers for additional info, clarifications, etc. is the delay. Then the Journal itself will have rules. Don't believe they will hold up timing much but will have a say in how and when TLD gets out in line with publication.
Not yet. They still need MHRA approval.
Low volume move down. Power hour will tell the tale.
Agreed. Simply parallel processes while getting to topline. Certainly speeds the process to approval (and revenue through UK Specials). To me it is crystal clear (tea leaves) that they are sitting on positive data or it would be corporate malfeasance to be spending money in a cart before the horse scenario for manufacturing. Not to mention we all know they would have had to announce negative data if that's what they are seeing. The paper, peer-review, and numerous consultants (SAB, Steering committee, etc.) is the reason for the delay. They could all come back to the table with their edits, findings, etc. at the same time and then we get topline. That is the wild card...along with whatever restrictions or rules from the Journal that accepts the article.
Let's see how the afternoon trading goes. Large asks and resistance at $1.20....or do we see profit taking from those who bought at $1. Hoping they stick around for a couple day run.
As frustrated as I am with the communication, I do know there is a lot that is out of their hands with regard to timing. I just hope that all the scientists, DR's, statisticians, etc. have an urgency to get this article out based on what they are seeing. Patients are dying and TLD and Journal are only the first steps in getting this to the point of saving lives.
I wouldn't be surprised to find out that the BLA has been submitted and will be announced with topline and Journal. The connecting-the-dots they have left us with points to that IMO. Lancet article, LL comments regarding historical comparison trials. I believe it is taking longer because everything is being done at the same time. Given that opinion, I don't expect topline until beginning of the year.
Would love it but doubt it. Too many cooks in the kitchen with their own pace of play. Timing is totally out of their hands at this point. Would be great if it all came together quickly but I am now in the first quarter camp for topline.
They PR'd the update and HTA license because the official MHRA approval time frame is out of their control now. Inspection done, probably a few minor corrections needed, then approval. Before year-end is probable given the HTA requirements are met, leaving less for MHRA issues, IMO. Next info will be 10Q, IMO. We can get a better handle on $11 million loan repayment (or restructure?). We will know the cash position better with cash conversions. Other than that this waiting period will continue until Journal. Hopefully most of the conversion and panic selling is done for now.
Yep. Selling will eventually end. I don't anticipate any news other than Sawston certification and 10Q in the next month. So, I think we float in this 1-1.30 range until news.
Still wouldn't make a lot of sense to me as most warrants were in friendly hands? Why would they sell before topline? Smells of financing, then dump.
Stop. Nothing but topline matters. Period. Certification for a product we don't have and can't sell is irrelevant.
LOL. They have had topline data for how long?
They have steps in a process, where are we?
Plenty to update. Simple.
The silence strategy at work again. Can't blame anyone for selling if they don't trust management. Simple updates would have prevented this last few months of drop in PPS.
Never was. I could care less about the May 12th PR. Never have talked about it or certification. It has been over 380 days post-data lock with no update on the trial. That is fact and it is irrefutable.
Certification has nothing to do with this. It's an add on. There was no talk about certifications when they said topline will be released last September. We are talking about trial results, topline, journal and the 6 step process they outlined over a year ago and given NO updates on since. "Working hard per the October 5th PR" is not an update.
You know YOUR reality. The reality is the company has been silent for over a year on trial data. Covid delays, Journal combined with topline...I get it and agreed with it, over a year ago. I have always, and still do, disagree with their strategy regarding communication. I also believe it conflicts with their fiduciary responsibilities to shareholders. LP is so afraid of the boogie man (shorts/AF/Etc.) that she can't see the silence is having the same effect. A simple update of the steps and where we are and another vague estimate to topline is fine. PPS would stabilize and move higher.
Collectively, there are likely 10's of millions of shares (or more) held by iHub board posters here. We could send a letter to the company endorsed by all asking for an update. I would not be surprised to see a class-action lawsuit demanding an update at some point. Any decent lawyer could cite their public statements from last year and then their abrupt change of direction into secrecy. I believe it would be heard.
Selectively PRing certifications? Supply chain issues? Seriously? First covid, now our problem is the docks of LA? Everything that needs to be done to release topline can be transferred at light speed between computers. More BS, IMO.
Not right. With 1.4 billion fully diluted shares, there is no way we get a $42 Billion market cap prior to approval to actually make/sell anything. $10 Would be great to start, then let the bidding begin.
To post that you actually know what is going on is fraud. I have never claimed fraud, just pointed out what has actually transpired. Everything you post is supposition and likely based on false assumptions. How else can it be? The company has said nothing about the trial in over a year? Where are you getting your info that apparently are more accurate than everyone else's?
Who, Me? JDheart, FeMike? All legitimate criticisms from longs. Just because we are not lemming-like and question this more-than-year-long "quiet period"? I don't trade the stock. I am not looking to buy more stock. I have a large position I have held for years. I want frigging topline data, yeah, the data they spoke publicly about releasing over a year ago.
Irrelevant. NWBO is a stand alone public company. No other company has access to data results or is exclusively tied to NWBO, even Advent. If NWBO tanks with bad results, Advent is set up to go find other clients. Not saying that's the plan, just saying they are completely separate entities.
They way this is trading, if we hold here through lunchtime, could pop to $1.15 or more to close. Chart, hunch...combined. The selling has to end sometime. News has to come sometime.
Might as well get the bear raid over with. This sideways and tight range was going to break one way or the other. And with ZERO news, downside was more likely. Let the selling happen and we move higher. Unfortunately, the move higher will be limited, but hopefully stabilizing until the company gives us something. Again, unfortunately, it will be the 10Q in two and a half weeks and the need to read tea leaves.
No word from Smith or Lappin or alphavest recently. No Word from MHRA and no word from the company. Deafening.
My point is tat the market has already priced a lot of that into the current price. MHRA does little, IMO. Positive topline gets us to $4-5/share if good, $8-10 if great, prior to approval. JMHO.
There is no buyout now or in the near future. LP controls the show and is stubborn to a fault, IMO. She actually still believes she can go it alone. SP increases with positive topline, period. Maybe a small pop with MHRA approval but that does little to justify a billion dollar valuation with only UK specials available.
Nope. I think he selectively replies to emails as well. Only responds to those who are willing to take non answers for answers. Won't respond to tough questions. You know, "quiet period"
Because it isn't done and officially approved yet.
Well, there won't be news on a Friday, IMO, so Monday is the next chance unless you think there will be something after the bell, which I don't.
Maybe they were some of his warrants and he exercised to help the company after his trip to Bethesda.
What are you talking about? You actually believe all warrants carry a cash exercise? LOL...forget my experience, which I guarantee blows yours away. As a series 7, 63, 24, and 27 licensed principal and finop (previous) for a nasdaq firm, I'm pretty sure I know what I'm talking about.